Table of Contents
ISRN Analytical Chemistry
Volume 2013, Article ID 534763, 8 pages
Research Article

Method Development and Validation for Estimation of Eperisone Hydrochloride as API and in Tablet Dosage Form by Two Spectroscopic Methods

Department of Quality Assurance, Lachoo Memorial College of Science & Technology (Autonomous), Jodhpur, Rajasthan 342003, India

Received 24 July 2013; Accepted 12 August 2013

Academic Editors: A. Garcia Asuero, S. Göktürk, A. Niazi, and A. Szemik-Hojniak

Copyright © 2013 Joytosh Banerjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Sittig, Pharmaceutical Manufacturing Encyclopaedia, vol. 2, William Andrew Publishing, New York, NY, USA, 3rd edition, 2007.
  2. S. C. Sweetman, Martindale: The Complete Drug Reference, Pharmaceutical Press, London, UK, 36th edition, 2009.
  3. S. R. Crouch, T. F. Cullen, A. Scheeline, and E. S. Kirkor, “Kinetic determinations and some kinetic aspects of analytical chemistry,” Analytical Chemistry, vol. 70, no. 12, pp. 53R–106R, 1998. View at Google Scholar
  4. H. L. Pardue, “Kinetic aspects of analytical chemistry,” Analytica Chimica Acta, vol. 216, no. C, pp. 69–107, 1989. View at Google Scholar · View at Scopus
  5. “Kinetic specroscopy,”, 2012.
  6. B. Melilli, C. Piazza, D. C. Vitale et al., “Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 36, no. 2, pp. 71–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Saito, T. Yamagiwa, Y. Yui et al., “Monolithic spin-column extraction and GC-MS method for the assay of eperisone in human serum,” Journal of Health Science, vol. 56, no. 5, pp. 598–605, 2010. View at Google Scholar · View at Scopus
  8. L. Ding, X. Wang, Z. Yang, and Y. Chen, “The use of HPLC/MS, GC/MS, NMR, UV and IR to identify a degradation product of eperisone hydrochloride in the tablets,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 2, pp. 282–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Wei, L. Ding, J. Gao et al., “Pharmacokinetics and bioequivalence of eperisone hydrochloride tablet in healthy subjects,” Yaoxue Xuebao, vol. 39, no. 4, pp. 309–311, 2004. View at Google Scholar · View at Scopus
  10. T. Takamatsu, K. Yamazaki, M. Kayano, F. Takenaka, M. Hasui, and T. Ohkawa, “Determination of eperisone in human plasma by gas chromatography-mass spectrometry,” Journal of Chromatography, vol. 584, no. 2, pp. 261–266, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Lunn, HPLC Methods for Recently Approved Pharmaceuticals, John Wiley & Sons, New Jersey, NJ, USA, 2005.
  12. Japanese Pharmacopoeia, Japanese Society of Pharmacopoeia, 15th edition, 2007.
  13. F. A. Skoog, F. J. Holler, and S. R. Crouch, “Introduction to UV spectroscopy,” in Principle of Instrumental Analysis, pp. 381–385, Brooks/Cole, Singapore, 6th edition, 2007. View at Google Scholar
  14. Z. D. Hill and P. MacCarthy, “Novel approach to job's method: an undergraduate experiment,” Journal of Chemical Education, vol. 63, no. 2, pp. 162–167, 1986. View at Google Scholar · View at Scopus
  15. International Conference on Harmonization (ICH), “Validation of analytical procedures: text and methodology,” Harmonized tripartite guideline Q2(R1), 2005.
  16. United States Pharmacopeia 34 and National Formulary 29, General Chapter 1225, Validation of Compendial Procedures, vol. 1, United States Pharmacopeial Convention, Rockville, Md, USA, 2011.
  17. I. A. Khan and A. Khanum, Biostats for Pharmacy, Ukaaz, Hyderabad, India, 2nd edition, 2008.
  18. S. Bolton and C. Bon, Pharmaceutical Statistics: Practical and Clinical Application, Informa Healthcare, New York, NY, USA, 5th edition, 2009.